Understanding BMI: What the Number Really Means
Body Mass Index (BMI) is the screening number you'll see on every chart and intake form. It's simple, free, and decades old — but it's also widely misunderstood. Here's what BMI actually measures, what it can and can't tell you, and how clinicians use it alongside other markers when deciding things like GLP-1 eligibility.
What BMI is (and isn't)
BMI is your weight in kilograms divided by your height in meters squared (kg/m²). It's a single number derived from two measurements — that's it. It does not measure body fat, muscle mass, bone density, or fat distribution.
It was designed in the 1830s as a population-level statistic and adopted by the WHO in the 1990s as a fast screening tool. The point was never precision for an individual — it was triage at scale.
The standard BMI categories
- Underweight: below 18.5
- Normal weight: 18.5 to 24.9
- Overweight: 25.0 to 29.9
- Obesity class I: 30.0 to 34.9
- Obesity class II: 35.0 to 39.9
- Obesity class III: 40 and above
These cutoffs come from population studies linking BMI ranges to relative risk of cardiovascular disease, type 2 diabetes, and all-cause mortality.
Why clinicians still use it
Despite well-known flaws, BMI remains the gatekeeper for things like GLP-1 prescriptions, bariatric surgery referrals, and insurance coverage. Most U.S. payers require a BMI ≥30, or ≥27 with at least one comorbidity (type 2 diabetes, hypertension, sleep apnea, dyslipidemia) before they'll cover Wegovy, Zepbound, or compounded semaglutide.
It's fast, free, and reproducible — three things insurers love. That's why every telehealth GLP-1 intake form starts with height and weight.
What BMI doesn't capture
BMI can't tell the difference between a 220 lb linebacker and a 220 lb sedentary office worker of the same height. Both score the same. It also doesn't account for waist-to-hip ratio, visceral fat (the dangerous kind around organs), or where on your body weight is distributed.
For a fuller picture, your clinician may add waist circumference, body fat percentage (DEXA or bioimpedance), A1C, fasting glucose, and lipid panel. See our companion piece on BMI's limitations for the full list.
Frequently asked
What BMI qualifies for GLP-1 medications?
Most payers require BMI ≥30, or ≥27 with a related condition like type 2 diabetes, hypertension, or sleep apnea. Cash-pay telehealth programs sometimes prescribe at lower BMIs, but the FDA labels for Wegovy and Zepbound match the payer thresholds.
Is BMI accurate for muscular people?
No. BMI counts muscle mass as 'weight' the same way it counts fat. Athletes and heavily resistance-trained people frequently score in the overweight or obese categories despite low body fat. In that case, body fat percentage and waist circumference are more useful.
Does BMI work the same across ethnicities?
Not exactly. Cardiometabolic risk rises at lower BMIs in many Asian populations, so the WHO uses an adjusted overweight cutoff of 23 and obesity cutoff of 27.5 for screening purposes in some Asian groups.
“Finally a weight-loss resource that explains the science without trying to sell me a supplement.”
“The BMI and GLP-1 guides helped me ask my doctor better questions. Clear, honest, and free.”
Find the right GLP-1 program for you
Take our 60-second quiz to match with a vetted telehealth provider.